DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Durect Corporation (DRRX)
« Back to company indexDRRX Chatter Timeline
Stock Ticker for DRRX
Most Active Tweeters for DRRX
| User | Tweets |
|---|---|
| @AmericanBanking | 2 |
| @insiderbuyings | 1 |
| @TranscriptDaily | 1 |
| @TickerReport | 1 |
| @ConsumerFeed | 1 |
Recent Tweets for DRRX
 |
@WOWlNV RT @LlcBillionaire: $DRRX head and shoulders June 17th 2019, 4:06am |
 |
@DataTrials $DRRX Phase 2 Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis… Estimate Pri… https://t.co/yyAGkMy9N7 June 16th 2019, 1:06pm |
 |
@ConsumerFeed DURECT Director Jon Saxe Buys $13,750.00 in $DRRX https://t.co/G0aUF8jrJa June 12th 2019, 3:06am |
 |
@insiderbuyings $DRRX new insider buying: 25000 shares. https://t.co/aC84iakDTU June 11th 2019, 11:06pm |
 |
@macondailynews Insider Buying: DURECT Co. $DRRX Director Acquires 25,000 Shares of Stock https://t.co/ZAPu7SteZ7 June 11th 2019, 11:06pm |
 |
@AmericanBanking DURECT Co. $DRRX Director Purchases $13,750.00 in Stock https://t.co/X1JxzIIGvK #stocks June 11th 2019, 11:06pm |
 |
@InsiderAlertsIA $DRRX: New Insider Filing on Director JON S SAXE: https://t.co/2DJEjn4r90 June 11th 2019, 8:06pm |
 |
@fintel_io Insider SAXE JON S reports buying 25,000 shares of $DRRX for a total cost of $13,749.86 https://t.co/PAfBfY4fPF June 11th 2019, 8:06pm |
 |
@Allstocknews $DRRX ALERT: New DURECT Corporation SEC Filing From our Stock News Alerts App June 11th 2019, 8:06pm |
 |
@StockTexts $DRRX DURECT Corporation SEC Filing: Form 4 https://t.co/EYEiUM0W0r June 11th 2019, 8:06pm |
 |
@TranscriptDaily DURECT Co. $DRRX Expected to Post Earnings of -$0.05 Per Share https://t.co/TxYadm0Xs4 June 9th 2019, 8:06pm |
 |
@LlcBillionaire $DRRX head and shoulders June 9th 2019, 6:06pm |
 |
@stocknewstimes DURECT Co. $DRRX Expected to Post Earnings of -$0.05 Per Share https://t.co/vH9JQSNWeK June 5th 2019, 8:06am |
 |
@SleekMoneycom DURECT Co. $DRRX Expected to Post Earnings of -$0.05 Per Share https://t.co/z6q3iEWWmo #investing June 5th 2019, 8:06am |
 |
@JackalTrading $DRRX looks ready to make some noise. June 4th 2019, 11:06am |
|
@AmericanBanking $4.05 Million in Sales Expected for DURECT Co. $DRRX This Quarter https://t.co/OSzysg10MR #stocks June 4th 2019, 4:06am |
 |
@TickerReport DURECT Co. $DRRX Expected to Announce Quarterly Sales of $4.05 Million https://t.co/h6e1CSf7hX June 4th 2019, 4:06am |
|
@LlcBillionaire $DRRX shall we head back up?? June 2nd 2019, 6:06pm |
|
@ConsumerFeed -$0.05 Earnings Per Share Expected for DURECT Co. $DRRX This Quarter https://t.co/2EKJGzGWVO June 2nd 2019, 4:06am |
|
@AmericanBanking Zacks: Analysts Anticipate DURECT Co. $DRRX to Announce -$0.05 EPS https://t.co/hBy7gXXBoE #stocks June 2nd 2019, 4:06am |
 |
@OlympiaReport DURECT Co. $DRRX Director Jon S. Saxe Buys 30,000 Shares https://t.co/KXjuPdTtjt May 31st 2019, 9:05am |
 |
@ZolmaxNews DURECT Co. $DRRX Director Jon S. Saxe Purchases 30,000 Shares https://t.co/eUizhE7GcD May 30th 2019, 9:05am |
 |
@ChartMill The technical rating of $DRRX is bad and it also does not present a quality setup at the moment.… https://t.co/IT6ikkgys0 May 29th 2019, 11:05am |
|
@WOWlNV RT @fintel_io: Insider SAXE JON S reports buying 30,000 shares of $DRRX for a total cost of $18,903.05 https://t.co/PAfBfY4fPF May 29th 2019, 8:05am |
|
@WOWlNV RT @WKRBNews: Insider Buying: DURECT Co. $DRRX Director Buys 30,000 Shares of Stock https://t.co/Gb69qAqDAL #markets May 29th 2019, 8:05am |
|
@WOWlNV RT @AmericanBanking: DURECT Co. $DRRX Director Purchases $18,900.00 in Stock https://t.co/Ufx86j2upC #stocks May 29th 2019, 8:05am |
|
@WOWlNV RT @insiderbuyings: $DRRX new insider buying: 30000 shares. https://t.co/aC84iakDTU May 29th 2019, 8:05am |
|
@WOWlNV RT @TheMarketsDaily: DURECT Co. $DRRX Director Jon S. Saxe Acquires 30,000 Shares https://t.co/U9UnG0CSn6 May 29th 2019, 8:05am |
 |
@TheMarketsDaily DURECT Co. $DRRX Director Jon S. Saxe Acquires 30,000 Shares https://t.co/U9UnG0CSn6 May 29th 2019, 7:05am |
|
@insiderbuyings $DRRX new insider buying: 30000 shares. https://t.co/aC84iakDTU May 28th 2019, 11:05pm |
|
@AmericanBanking DURECT Co. $DRRX Director Purchases $18,900.00 in Stock https://t.co/Ufx86j2upC #stocks May 28th 2019, 8:05pm |
 |
@WKRBNews Insider Buying: DURECT Co. $DRRX Director Buys 30,000 Shares of Stock https://t.co/Gb69qAqDAL #markets May 28th 2019, 8:05pm |
|
@InsiderAlertsIA $DRRX: New Insider Filing on Director JON S SAXE: https://t.co/FUC9GbrR8h May 28th 2019, 8:05pm |
|
@fintel_io Insider SAXE JON S reports buying 30,000 shares of $DRRX for a total cost of $18,903.05 https://t.co/PAfBfY4fPF May 28th 2019, 7:05pm |
 |
@confcalltran Durect Corporation director just picked up 30,000 shares https://t.co/IGtxdVzrAk $DRRX May 28th 2019, 7:05pm |
 |
@3TriggersTrader $DRRX 6035.going.vertical-up.at-the-open May 28th 2019, 7:05am |
|
@WOWlNV RT @LlcBillionaire: $DRRX Resistance from 20 and 50 MA May 27th 2019, 7:05pm |
|
@LlcBillionaire $DRRX Resistance from 20 and 50 MA May 27th 2019, 3:05pm |
|
@WOWlNV RT @AnalystsAnalyst: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/q0bSddtTn6 $DRRX #biotech #smallcap… May 24th 2019, 6:05pm |
 |
@AnalystsAnalyst $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/q0bSddtTn6 $DRRX #biotech… https://t.co/NMD5gVKlmf May 24th 2019, 9:05am |
|
@stocknewstimes DURECT $DRRX Trading Down 16.7% https://t.co/rBUOLKRJSD May 23rd 2019, 9:05pm |
|
@SleekMoneycom DURECT $DRRX Trading Down 16.7% https://t.co/yKudzkrlON #investing May 23rd 2019, 9:05pm |
|
@WOWlNV RT @ZacksAwareness: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/NlUc4nlS4E $DRRX #biotech #smallcap… May 23rd 2019, 7:05pm |
|
@WOWlNV RT @risk_averse_: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/iYeRGzb5zV $DRRX #biotech #smallcap ht… May 23rd 2019, 7:05pm |
|
@WOWlNV RT @ContentCarnivor: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/xfaDKJjKJk $DRRX #biotech #smallcap… May 23rd 2019, 7:05pm |
 |
@ContentCarnivor $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/xfaDKJjKJk $DRRX #biotech… https://t.co/VkYRQWV6pO May 23rd 2019, 5:05pm |
 |
@risk_averse_ $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/iYeRGzb5zV $DRRX #biotech… https://t.co/mKtqUvfduG May 23rd 2019, 3:05pm |
 |
@ZacksAwareness $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/NlUc4nlS4E $DRRX #biotech… https://t.co/trF338sWB5 May 23rd 2019, 9:05am |
|
@WOWlNV RT @ahighelevation: $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/8grI0dqOmp $DRRX #biotech #smallcap… May 23rd 2019, 9:05am |
 |
@ahighelevation $DRRX Highly Compelling Initial Ph2a DUR-928 Alcoholic Hepatitis Data https://t.co/8grI0dqOmp $DRRX #biotech… https://t.co/Z7CummpRzR May 23rd 2019, 5:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.